Spc Financial, Inc. Alaunos Therapeutics, Inc. Transaction History

Spc Financial, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	BUY	$1.44 - $2.73 $432 - $819	300 Added 2.44%	12,600 $23,000
Q2 2021 Jul 29, 2021	BUY	$2.63 - $3.67 $3,945 - $5,505	1,500 Added 13.89%	12,300 $32,000
Q1 2021 Apr 22, 2021	BUY	$2.82 - $5.6 $30,456 - $60,479	10,800 New	10,800 $39,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $424M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Spc Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Spc Financial, Inc. with notifications on news.